Your browser doesn't support javascript.
loading
POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33.
Hitomi, Yuki; Ueno, Kazuko; Kawai, Yosuke; Nishida, Nao; Kojima, Kaname; Kawashima, Minae; Aiba, Yoshihiro; Nakamura, Hitomi; Kouno, Hiroshi; Kouno, Hirotaka; Ohta, Hajime; Sugi, Kazuhiro; Nikami, Toshiki; Yamashita, Tsutomu; Katsushima, Shinji; Komeda, Toshiki; Ario, Keisuke; Naganuma, Atsushi; Shimada, Masaaki; Hirashima, Noboru; Yoshizawa, Kaname; Makita, Fujio; Furuta, Kiyoshi; Kikuchi, Masahiro; Naeshiro, Noriaki; Takahashi, Hironao; Mano, Yutaka; Yamashita, Haruhiro; Matsushita, Kouki; Tsunematsu, Seiji; Yabuuchi, Iwao; Nishimura, Hideo; Shimada, Yusuke; Yamauchi, Kazuhiko; Komatsu, Tatsuji; Sugimoto, Rie; Sakai, Hironori; Mita, Eiji; Koda, Masaharu; Nakamura, Yoko; Kamitsukasa, Hiroshi; Sato, Takeaki; Nakamuta, Makoto; Masaki, Naohiko; Takikawa, Hajime; Tanaka, Atsushi; Ohira, Hiromasa; Zeniya, Mikio; Abe, Masanori; Kaneko, Shuichi.
Afiliação
  • Hitomi Y; Department of Human Genetics, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
  • Ueno K; Department of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
  • Kawai Y; Graduate School of Medicine, Tohoku University, Sendai, Japan.
  • Nishida N; Department of Human Genetics, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
  • Kojima K; The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Japan.
  • Kawashima M; Department of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
  • Aiba Y; Graduate School of Medicine, Tohoku University, Sendai, Japan.
  • Nakamura H; Japan Science and Technology Agency (JST), Tokyo, Japan.
  • Kouno H; Clinical Research Center, National Hospital Organization (NHO) Nagasaki Medical Center, Omura, Japan.
  • Kouno H; Clinical Research Center, National Hospital Organization (NHO) Nagasaki Medical Center, Omura, Japan.
  • Ohta H; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Sugi K; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Nikami T; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Yamashita T; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Katsushima S; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Komeda T; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Ario K; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Naganuma A; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Shimada M; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Hirashima N; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Yoshizawa K; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Makita F; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Furuta K; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Kikuchi M; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Naeshiro N; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Takahashi H; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Mano Y; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Yamashita H; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Matsushita K; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Tsunematsu S; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Yabuuchi I; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Nishimura H; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Shimada Y; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Yamauchi K; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Komatsu T; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Sugimoto R; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Sakai H; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Mita E; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Koda M; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Nakamura Y; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Kamitsukasa H; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Sato T; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Nakamuta M; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Masaki N; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Takikawa H; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Tanaka A; Headquarters of PBC Research in NHO Study Group for Liver Disease in Japan (NHOSLJ), Clinical Research Center, NHO Nagasaki Medical Center, Omura, Japan.
  • Ohira H; Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.
  • Zeniya M; Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.
  • Abe M; Department of Gastroenterology and Rheumatic Diseases, Fukushima Medical University of Medicine, Fukushima, Japan.
  • Kaneko S; Department of Gastroenterology and Hepatology, Tokyo Jikei University School of Medicine, Tokyo, Japan.
Sci Rep ; 9(1): 102, 2019 01 14.
Article em En | MEDLINE | ID: mdl-30643196
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polimorfismo de Nucleotídeo Único / Glucosiltransferases / Cirrose Hepática Biliar Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polimorfismo de Nucleotídeo Único / Glucosiltransferases / Cirrose Hepática Biliar Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article